240 related articles for article (PubMed ID: 21574647)
21. Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.
Wulfkuhle JD; Berg D; Wolff C; Langer R; Tran K; Illi J; Espina V; Pierobon M; Deng J; DeMichele A; Walch A; Bronger H; Becker I; Waldhör C; Höfler H; Esserman L; ; Liotta LA; Becker KF; Petricoin EF
Clin Cancer Res; 2012 Dec; 18(23):6426-35. PubMed ID: 23045247
[TBL] [Abstract][Full Text] [Related]
22. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
[TBL] [Abstract][Full Text] [Related]
23. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
25. Extracellular vesicles shed from gefitinib-resistant nonsmall cell lung cancer regulate the tumor microenvironment.
Choi DY; You S; Jung JH; Lee JC; Rho JK; Lee KY; Freeman MR; Kim KP; Kim J
Proteomics; 2014 Aug; 14(16):1845-56. PubMed ID: 24946052
[TBL] [Abstract][Full Text] [Related]
26. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
Grubb RL; Deng J; Pinto PA; Mohler JL; Chinnaiyan A; Rubin M; Linehan WM; Liotta LA; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2009 Jun; 8(6):3044-54. PubMed ID: 19275204
[TBL] [Abstract][Full Text] [Related]
27. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.
Nanjundan M; Byers LA; Carey MS; Siwak DR; Raso MG; Diao L; Wang J; Coombes KR; Roth JA; Mills GB; Wistuba II; Minna JD; Heymach JV
J Thorac Oncol; 2010 Dec; 5(12):1894-904. PubMed ID: 21124077
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
29. PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation.
Salama MF; Liu M; Clarke CJ; Espaillat MP; Haley JD; Jin T; Wang D; Obeid LM; Hannun YA
Oncogene; 2019 Nov; 38(48):7311-7328. PubMed ID: 31420605
[TBL] [Abstract][Full Text] [Related]
30. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
[TBL] [Abstract][Full Text] [Related]
31. EGFR mutation status in brain metastases of non-small cell lung carcinoma.
Burel-Vandenbos F; Ambrosetti D; Coutts M; Pedeutour F
J Neurooncol; 2013 Jan; 111(1):1-10. PubMed ID: 23086434
[TBL] [Abstract][Full Text] [Related]
32. A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.
Sanz-Pamplona R; García-García J; Franco S; Messeguer X; Driouch K; Oliva B; Sierra A
Mol Biosyst; 2012 Aug; 8(8):2085-96. PubMed ID: 22710377
[TBL] [Abstract][Full Text] [Related]
33. Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.
Garon EB; Finn RS; Hosmer W; Dering J; Ginther C; Adhami S; Kamranpour N; Pitts S; Desai A; Elashoff D; French T; Smith P; Slamon DJ
Mol Cancer Ther; 2010 Jul; 9(7):1985-94. PubMed ID: 20587667
[TBL] [Abstract][Full Text] [Related]
34. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.
Wrona A; Dziadziuszko R; Jassem J
Cancer Treat Rev; 2018 Dec; 71():59-67. PubMed ID: 30366200
[TBL] [Abstract][Full Text] [Related]
35. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
Saad AG; Yeap BY; Thunnissen FB; Pinkus GS; Pinkus JL; Loda M; Sugarbaker DJ; Johnson BE; Chirieac LR
Cancer; 2008 Oct; 113(8):2129-38. PubMed ID: 18720359
[TBL] [Abstract][Full Text] [Related]
37. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
[TBL] [Abstract][Full Text] [Related]
38. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
[TBL] [Abstract][Full Text] [Related]
39. CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain.
Cavallaro S
Int J Mol Sci; 2013 Jan; 14(1):1713-27. PubMed ID: 23322021
[TBL] [Abstract][Full Text] [Related]
40. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]